General MedicationsINJECTIONGeneric
POLOCAINE
MEPIVACAINE HYDROCHLORIDE
Standard Dose
3%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview POLOCAINE is listed in Drugs@FDA under application 088653 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient MEPIVACAINE HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - 3% Sponsor DENTSPLY PHARM Submission history Latest submission status date: 2019-01-15 00:00:00.
Structured Monograph
Clinical summary
Approval overview POLOCAINE is listed in Drugs@FDA under application 088653 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient MEPIVACAINE HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - 3% Sponsor DENTSPLY PHARM Submission history Latest submission status date: 2019-01-15 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.